
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cancer Statistics, 2021
Rebecca L. Siegel, Kimberly D. Miller, Hannah E. Fuchs, et al.
CA A Cancer Journal for Clinicians (2021) Vol. 71, Iss. 1, pp. 7-33
Open Access | Times Cited: 14602
Rebecca L. Siegel, Kimberly D. Miller, Hannah E. Fuchs, et al.
CA A Cancer Journal for Clinicians (2021) Vol. 71, Iss. 1, pp. 7-33
Open Access | Times Cited: 14602
Showing 26-50 of 14602 citing articles:
Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?
María Vallet‐Regí, Ferdi Schüth, Daniel Lozano, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 13, pp. 5365-5451
Open Access | Times Cited: 271
María Vallet‐Regí, Ferdi Schüth, Daniel Lozano, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 13, pp. 5365-5451
Open Access | Times Cited: 271
Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer
Jamie E. Chaft, Andreas Rimner, Walter Weder, et al.
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 9, pp. 547-557
Open Access | Times Cited: 261
Jamie E. Chaft, Andreas Rimner, Walter Weder, et al.
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 9, pp. 547-557
Open Access | Times Cited: 261
Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non–Small-Cell Lung Cancer (NADIM phase II trial)
Mariano Provencio, Roberto Serna‐Blasco, Ernest Nadal, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 25, pp. 2924-2933
Open Access | Times Cited: 244
Mariano Provencio, Roberto Serna‐Blasco, Ernest Nadal, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 25, pp. 2924-2933
Open Access | Times Cited: 244
The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives
Shun Wang, Yan Zheng, Yang Feng, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 230
Shun Wang, Yan Zheng, Yang Feng, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 230
Signal pathways of melanoma and targeted therapy
Weinan Guo, Huina Wang, Chunying Li
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 223
Weinan Guo, Huina Wang, Chunying Li
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 223
KRAS mutation in pancreatic cancer
Ji Luo
Seminars in Oncology (2021) Vol. 48, Iss. 1, pp. 10-18
Open Access | Times Cited: 215
Ji Luo
Seminars in Oncology (2021) Vol. 48, Iss. 1, pp. 10-18
Open Access | Times Cited: 215
Colorectal Cancer Screening
Amy B. Knudsen, Carolyn M. Rutter, Elisabeth F. P. Peterse, et al.
JAMA (2021) Vol. 325, Iss. 19, pp. 1998-1998
Open Access | Times Cited: 215
Amy B. Knudsen, Carolyn M. Rutter, Elisabeth F. P. Peterse, et al.
JAMA (2021) Vol. 325, Iss. 19, pp. 1998-1998
Open Access | Times Cited: 215
The Chemistry of Organic Contrast Agents in the NIR‐II Window
Jing Mu, Ming Xiao, Yu Shi, et al.
Angewandte Chemie International Edition (2021) Vol. 61, Iss. 14
Closed Access | Times Cited: 213
Jing Mu, Ming Xiao, Yu Shi, et al.
Angewandte Chemie International Edition (2021) Vol. 61, Iss. 14
Closed Access | Times Cited: 213
Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review
Jinshou Yang, Ruiyuan Xu, Chengcheng Wang, et al.
Cancer Communications (2021) Vol. 41, Iss. 12, pp. 1257-1274
Open Access | Times Cited: 208
Jinshou Yang, Ruiyuan Xu, Chengcheng Wang, et al.
Cancer Communications (2021) Vol. 41, Iss. 12, pp. 1257-1274
Open Access | Times Cited: 208
Single-cell spatial landscapes of the lung tumour immune microenvironment
Mark Sorin, Morteza Rezanejad, Elham Karimi, et al.
Nature (2023) Vol. 614, Iss. 7948, pp. 548-554
Open Access | Times Cited: 203
Mark Sorin, Morteza Rezanejad, Elham Karimi, et al.
Nature (2023) Vol. 614, Iss. 7948, pp. 548-554
Open Access | Times Cited: 203
Mesenchymal stem/stromal cells in cancer therapy
Tianxia Lan, Min Luo, Xiawei Wei
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 202
Tianxia Lan, Min Luo, Xiawei Wei
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 202
Detecting Liquid Remnants of Solid Tumors: Circulating Tumor DNA Minimal Residual Disease
Everett J. Moding, Barzin Y. Nabet, Ash A. Alizadeh, et al.
Cancer Discovery (2021) Vol. 11, Iss. 12, pp. 2968-2986
Open Access | Times Cited: 193
Everett J. Moding, Barzin Y. Nabet, Ash A. Alizadeh, et al.
Cancer Discovery (2021) Vol. 11, Iss. 12, pp. 2968-2986
Open Access | Times Cited: 193
Wnt signaling pathway: A comprehensive review
Rabia Hayat, Maleeha Manzoor, Ali Hussain
Cell Biology International (2022) Vol. 46, Iss. 6, pp. 863-877
Closed Access | Times Cited: 193
Rabia Hayat, Maleeha Manzoor, Ali Hussain
Cell Biology International (2022) Vol. 46, Iss. 6, pp. 863-877
Closed Access | Times Cited: 193
American Cancer Society's report on the status of cancer disparities in the United States, 2021
Farhad Islami, Carmen E. Guerra, Adair K. Minihan, et al.
CA A Cancer Journal for Clinicians (2021) Vol. 72, Iss. 2, pp. 112-143
Open Access | Times Cited: 188
Farhad Islami, Carmen E. Guerra, Adair K. Minihan, et al.
CA A Cancer Journal for Clinicians (2021) Vol. 72, Iss. 2, pp. 112-143
Open Access | Times Cited: 188
Recent advances in exosome-mediated nucleic acid delivery for cancer therapy
Ying Zhang, Qiqi Liu, Xinmeng Zhang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 185
Ying Zhang, Qiqi Liu, Xinmeng Zhang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 185
Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance
Xiaowei Liu, Jinen Song, Hao Zhang, et al.
Cancer Cell (2023) Vol. 41, Iss. 2, pp. 272-287.e9
Open Access | Times Cited: 183
Xiaowei Liu, Jinen Song, Hao Zhang, et al.
Cancer Cell (2023) Vol. 41, Iss. 2, pp. 272-287.e9
Open Access | Times Cited: 183
Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance
Kai Fu, Fachao Xie, Fang Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 177
Kai Fu, Fachao Xie, Fang Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 177
Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Patrick A. Brown, Bijal Shah, Anjali S. Advani, et al.
Journal of the National Comprehensive Cancer Network (2021) Vol. 19, Iss. 9, pp. 1079-1109
Open Access | Times Cited: 173
Patrick A. Brown, Bijal Shah, Anjali S. Advani, et al.
Journal of the National Comprehensive Cancer Network (2021) Vol. 19, Iss. 9, pp. 1079-1109
Open Access | Times Cited: 173
Designer exosomes for targeted and efficient ferroptosis induction in cancer via chemo-photodynamic therapy
Jianbing Du, Zhuo Wan, Cong Wang, et al.
Theranostics (2021) Vol. 11, Iss. 17, pp. 8185-8196
Open Access | Times Cited: 171
Jianbing Du, Zhuo Wan, Cong Wang, et al.
Theranostics (2021) Vol. 11, Iss. 17, pp. 8185-8196
Open Access | Times Cited: 171
Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update
Nancy N. Baxter, Erin B. Kennedy, Emily K. Bergsland, et al.
Journal of Clinical Oncology (2021) Vol. 40, Iss. 8, pp. 892-910
Open Access | Times Cited: 171
Nancy N. Baxter, Erin B. Kennedy, Emily K. Bergsland, et al.
Journal of Clinical Oncology (2021) Vol. 40, Iss. 8, pp. 892-910
Open Access | Times Cited: 171
Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC
Xing Niu, Lijie Chen, Yan Li, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 273-285
Closed Access | Times Cited: 169
Xing Niu, Lijie Chen, Yan Li, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 273-285
Closed Access | Times Cited: 169
Lung cancer statistics, 2023
Tyler B. Kratzer, Priti Bandi, Neal D. Freedman, et al.
Cancer (2024) Vol. 130, Iss. 8, pp. 1330-1348
Closed Access | Times Cited: 169
Tyler B. Kratzer, Priti Bandi, Neal D. Freedman, et al.
Cancer (2024) Vol. 130, Iss. 8, pp. 1330-1348
Closed Access | Times Cited: 169
Current State of Breast Cancer Diagnosis, Treatment, and Theranostics
Arya Bhushan, Andrea Gonsalves, Jyothi U. Menon
Pharmaceutics (2021) Vol. 13, Iss. 5, pp. 723-723
Open Access | Times Cited: 168
Arya Bhushan, Andrea Gonsalves, Jyothi U. Menon
Pharmaceutics (2021) Vol. 13, Iss. 5, pp. 723-723
Open Access | Times Cited: 168
IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment
Sara G. Manore, Daniel Doheny, Grace L. Wong, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 163
Sara G. Manore, Daniel Doheny, Grace L. Wong, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 163
Artificial intelligence system reduces false-positive findings in the interpretation of breast ultrasound exams
Yiqiu Shen, Farah E. Shamout, Jamie R. Oliver, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 160
Yiqiu Shen, Farah E. Shamout, Jamie R. Oliver, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 160